Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Merit Medical Systems, Inc. (MMSI) had Cost of Goods Sold of $777.64M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$1.52B
Net Income	$128.49M
Cost of Goods Sold	$777.64M
Gross Profit	$738.27M
Operating Expenses	$1.33B
Operating Income	$184.72M
Non-Operating Income/Expense	$-13.78M
Pre-Tax Income	$170.94M
Normalized Pre-Tax Income	$170.94M
Income after Taxes	$128.49M
Income from Continuous Operations	$128.49M
Consolidated Net Income/Loss	$128.49M
Normalized Income after Taxes	$128.49M
EBIT	$184.72M
EBITDA	$324.92M
Weighted-Average Shares Outstanding (Basic)	59.16M
Weighted-Average Shares Outstanding (Diluted)	60.46M
Earnings per Share (EPS) (Basic)	$2.17
Earnings per Share (EPS) (Diluted)	$2.13
Balance Sheet Financials
Current Assets	$1.04B
Property, Plant, and Equipment	$428.40M
Long-Term Assets	$1.65B
Total Assets	$2.69B
Current Liabilities	$239.76M
Long-Term Debt	$734.04M
Long-Term Liabilities	$861.86M
Total Liabilities	$1.10B
Common Equity	$1.58B
Tangible Shareholders Equity	$539.81M
Shareholders Equity	$1.58B
Common Shares Outstanding	59.42M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$297.37M
Cash Flow from Investing Activities	$-247.39M
Cash Flow from Financial Activities	$16.00M
Beginning Cash	$378.77M
End Cash	$448.55M
Increase/Decrease in Cash	$69.78M
Stock-Based Compensation	$43.46M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.34
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.32
Debt to Equity Ratio	0.46
Gross Margin	48.70%
Operating Margin	12.19%
EBIT Margin	12.19%
EBITDA Margin	21.43%
Pre-Tax Profit Margin	11.28%
Profit Margin	8.48%
Free Cash Flow	$215.66M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.56
Inventory Turnover	2.33
Receiveable Turnover	6.63
Days Sales in Receivables	55.03
Return on Equity	8.11%
Return on Tangible Equity	23.80%
Return on Assets	4.78%
Return on Investments	5.54%
Book Value Per Share	$26.66
Free Cash Flow per Share	$3.57
Operating Cash Flow per Share	$4.92

Data from Zacks Investment Research, Inc.